Anton Uvarov
Co-Founder, Executive Director at NeuroScientific Biopharmaceuticals Ltd | Perth, Western Australia, Australia
Anton Uvarov’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
Director at Nutritional Growth Solutions in November 2026 - November 2026
Director at ParaZero Drone Safety Systems in November 2026 - November 2026
Director at Elsight in November 2026 - November 2026
Director at HearMeOut in November 2026 - November 2026
Director at Actinogen Medical in November 2026 - November 2026
Advisor at Forrest Capital in November 2026 - November 2026
Advisor at Albion Capital Partners in November 2026 - November 2026
Director at Imugene Limited in November 2026 - November 2026
Co-Founder, Executive Director at NeuroScientific Biopharmaceuticals Ltd in November 2026 - Present
Co-Founder, Director at NeuroScientific Biopharmaceuticals Ltd in November 2026 - Present
Co-Founder, Executive Director at BLINKLAB - Neurobehavioral Testing in November 2026 - Present
Haskayne School of Business, MBA
University of Manitoba, Doctor of Philosophy (Ph.D.)
BlinkLab Limited was founded by neuroscientists at Princeton University and is developing a smartphone-based diagnostic platform for autism. Its most advanced product, BlinkLab Dx1, is an autism diagnostic aid for clinicians that leverages smartphones, artificial intelligence, and machine learning to capture objective, reflex-based measures, supporting earlier and more accurate autism identification. This enables timely intervention during critical periods of brain development. BlinkLab is led by an experienced management team and Board with deep expertise in digital healthcare, computer vision, and AI, supported by a Scientific Advisory Board of leading experts in autism and brain development.
Discover more about NeuroScientific Biopharmaceuticals Ltd
Cofounder and CEO BlinkLab Ltd, Neuroscientist
Chief Executive Officer at BLINKLAB - Neuro Behavioral Testing
(Aug 2021 – Present)
Chairman, BlinkLab Limited. Co-founder and Executive Director at ResApp Health Limited (acquired by Pfizer in September 2022)
BlinkLab (ASX:BB1) was the first healthcare IPO of 2024 in a heavily oversubscribed $7m prospectus raising. A digital healthcare company with an exclusive license from Princeton University, BlinkLab is developing a smartphone application to diagnose Autism/ADHD in children as ...
MSc Neuroscience, Erasmus Mundus | Translational & Clinical Research | Neuroscience & Mental Health Outreach
Research Manager at BlinkLab Limited (ASX:BB1)
(May 2025 – Present)
iOS Developer @ BlinkLab | iOS Mobile Architect | iOS Development Mentor | AI Enthusiast
iOS Developer at BlinkLab Limited (ASX:BB1)
(Sep 2025 – Present)
Clinical Adoption & Strategy at BlinkLab | Technical Physician
Clinical Adoption & Strategy Lead at BlinkLab Limited (ASX:BB1)
(Feb 2026 – Present)
NeuroData Erasmus Mundus Joint Master Scholar | GSoC ’23 @INCF
Junior Full Stack Data Scientist at BlinkLab Limited (ASX:BB1)
(Oct 2025 – Present)
What is Anton Uvarov email address?
Email Anton Uvarov at [email protected] and [email protected]. This email is the most updated Anton Uvarov's email found in 2026.
How to contact Anton Uvarov?
To contact Anton Uvarov send an email to [email protected] or [email protected].
What company does Anton Uvarov work for?
Anton Uvarov works for NeuroScientific Biopharmaceuticals Ltd.
What is Anton Uvarov's role at NeuroScientific Biopharmaceuticals Ltd?
Anton Uvarov is Co-Founder, Executive Director
What industry does Anton Uvarov work in?
Anton Uvarov works in the Venture Capital & Private Equity industry.
